Search results
Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to...
Simply Wall St. via Yahoo Finance· 1 day agoThe group holding the most number of shares in the company, around 61% to be precise, is...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 4 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Geron Co. (NASDAQ:GERN) EVP Faye Feller Sells 287,900 Shares of Stock
ETF DAILY NEWS· 1 day agoGeron Co. (NASDAQ:GERN – Get Free Report) EVP Faye Feller sold 287,900 shares of the company’s stock in a transaction dated Monday, June 10th. Geron Co. has a 12 month low ...
Why Is Geron (GERN) Stock Up 18% Today?
InvestorPlace· 7 days agoGeron (NASDAQ:GERN) stock is heading higher on Friday after getting approval from the U.S. Food and Drug Administration (FDA) for RYTELO. RYTELO is the...
Geron (NASDAQ:GERN) Now Covered by Analysts at Barclays
ETF DAILY NEWS· 4 days agoEquities researchers at Barclays started coverage on shares of Geron (NASDAQ:GERN – Get Free Report) in a research note issued to investors on Monday, Benzinga reports. The ...
Geron stock steady as analysts maintain 'buy' rating with $10 target By Investing.com
Investing.com· 7 days agoOn Friday, TD (TSX:TD) Cowen reaffirmed its confidence in Geron (NASDAQ:GERN) Corporation (NASDAQ:...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 7 days agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 6 days agoShares of Geron (NASDAQ: GERN) finished the week ended June 7 about 32% higher. The market was...
Geron Corp stock opened 25% up on Friday: here's why | Invezz
Invezz· 7 days agoAre you looking for signals & alerts from pro-traders? The Food & Drug Administration approved its lead asset as a late-line treatment for myelodysplastic syndromes (MDS). The telomerase inhibitor ...
Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 7 days agoPerformance of an Industry Player Exact Sciences belongs to the Zacks Medical - Biomedical and...